Comparative study of the effect of intranasal insulin on memory deficits in type 2 diabetes and early Alzheimer´s dementia (INSULA)
Phase of Trial: Phase II
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Insulin aspart (Primary)
- Indications Alzheimer's disease; Mild cognitive impairment; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms INSULA
- 09 Mar 2016 Status changed from recruiting to discontinued, according to European Clinical Trials Database record.
- 23 May 2013 New source identified and integrated (European Clinical Trials Database: EudraCT2008-008555-41).
- 15 Nov 2012 Status changed from planning to recruiting as reported by German Clinical Trials Register record.